AI-Assisted OCT Clinical Phenotypes of Diabetic Macular Edema: A Large Cohort Clustering Study
- PMID: 41302929
- PMCID: PMC12653931
- DOI: 10.3390/jcm14227893
AI-Assisted OCT Clinical Phenotypes of Diabetic Macular Edema: A Large Cohort Clustering Study
Abstract
Purpose: To characterize, using clustering analysis, the OCT morphological and clinical phenotypes of diabetic macular edema (DME) in a very large population (>2000 DME eyes) using standardized and validated OCT-based biomarkers. Methods: A cross-sectional study was conducted on OCT scans collected from 2355 eyes of 1688 patients with DME and performed during real-world clinical practice. OCT scans were automatically analyzed by a software able to automatically quantify OCT key biomarkers: intraretinal fluid (IRF), subretinal fluid (SRF), hyperreflective retinal foci (I-HRF), and external limiting membrane (ELM) and ellipsoid zone (EZ) interruption. Clustering analysis was performed using the above-mentioned biomarkers, including the distribution of IRF across the three ETDRS rings. Results: The overall population was predominantly composed of type 2 diabetes patients (89%), with a mean diabetes duration of 15.6 ± 10.7 years and mean best corrected visual acuity (BCVA) of 63 ± 18 ETDRS letters. Multivariate clustering identified four morphological phenotypes with distinct patterns of fluid distribution associated with different I-HRF counts, SRF volume, and percentages of ELM/EZ integrity (p < 0.0001). Conclusions: This large OCT analysis identified distinct morphological subtypes of DME, confirming the clinical relevance of key imaging biomarkers. The distribution and severity of DME features differ among clusters, supporting the importance of OCT-based phenotyping in tailoring treatment strategies and understanding disease evolution.
Keywords: biomarkers; clinical phenotypes; clustering analysis; diabetic macular edema; ellipsoid zone; external limiting membrane; hyperreflective retinal foci; intraretinal fluid; optical coherence tomography; subretinal fluid.
Conflict of interest statement
This study was promoted by the Italian Retina Society (SIR) and the authors declare no conflicts of interest for this study.
References
-
- Teo Z.L., Tham Y.-C., Yu M., Chee M.L., Rim T.H., Cheung N., Bikbov M.M., Wang Y.X., Tang Y., Lu Y., et al. Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis. Ophthalmology. 2021;128:1580–1591. doi: 10.1016/j.ophtha.2021.04.027. - DOI - PubMed
-
- International Diabetes Federation (IDF) [(accessed on 22 August 2025)]. Available online: https://diabetesatlas.org/
-
- IDF-Italy-Diabetes Country Report 2000–2050. [(accessed on 22 August 2025)]. Available online: https://diabetesatlas.org/data-by-location/country/italy/
-
- Midena E., Pilotto E. Emerging Insights into Pathogenesis. Dev. Ophthalmol. 2017;60:16–27. - PubMed
-
- Schmidt-Erfurth U., Garcia-Arumi J., Bandello F., Berg K., Chakravarthy U., Gerendas B.S., Jonas J., Larsen M., Tadayoni R., Loewenstein A. Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA) Ophthalmologica. 2017;237:185–222. doi: 10.1159/000458539. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous
